Talhia Tuck
Director/Board Member bij TELOMIR PHARMACEUTICALS, INC.
Vermogen: 273 222 $ op 31-03-2024
Profiel
Talhia T.
Tuck is an Independent Director at Telomir Pharmaceuticals, Inc. She previously worked as an Associate Director-Admissions at Georgetown University from 2016 to 2019.
She also served as an Independent Director at MIRA Pharmaceuticals, Inc. from 2021 to 2024.
Additionally, Talhia held the position of VP-Communications & Investor Relations at Rock Creek Pharmaceuticals, Inc. She completed her undergraduate degree at Harvard University in 2000 and obtained her graduate degree from Harvard Law School in 2010.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-03-2024 | 48 781 ( 0.16% ) | 251 222 $ | 31-03-2024 | |
| 03-08-2023 | 20 000 ( 0.14% ) | 22 000 $ | 31-03-2024 |
Actieve functies van Talhia Tuck
| Bedrijven | Functie | Begin |
|---|---|---|
| TELOMIR PHARMACEUTICALS, INC. | Director/Board Member | 01-11-2022 |
Eerdere bekende functies van Talhia Tuck
| Bedrijven | Functie | Einde |
|---|---|---|
| MIRA PHARMACEUTICALS, INC. | Director/Board Member | 09-03-2024 |
| Georgetown University | Corporate Officer/Principal | 01-01-2019 |
| ROCK CREEK PHARMACEUTICALS, INC. | Investor Relations Contact | 01-04-2014 |
| ROCK CREEK PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Opleiding van Talhia Tuck
| Harvard University | Undergraduate Degree |
| Harvard Law School | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MIRA PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Rock Creek Pharmaceuticals, Inc.
 Rock Creek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rock Creek Pharmaceuticals, Inc. is an early stage life science company, which engages in the discovery, development, and commercialization of new drugs, formulations, and compounds that provide therapies for chronic and acute inflammatory diseases. It focuses on small molecule therapeutics that exhibit anti-inflammatory pharmacological characteristics. The company was founded by Jonnie R. Williams, Sr. on June 24, 1985 and is headquartered in Sarasota, FL. | Health Technology |
| Telomir Pharmaceuticals, Inc. |
